Short answer
Tango Therapeutics, Inc. (TNGX) filed an 8-K current report with the SEC on March 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 2025 earnings press release filed as Exhibit 99.1; full financials and commentary available there.
Tango Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 2025 earnings press release filed as Exhibit 99.1; full financials and commentary available there
- Period covered: quarter ended December 31, 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tango Therapeutics, Inc. 8-K filings
Get the next TNGX 8-K as it lands
Follow TNGX for push alerts, or ask the research agent what this filing means.